A-CHMINACA, (ACHMINACA, Adamantyl-CHMINACA, SGT-37), is an indazole-based synthetic cannabinoid that binds to the CB1 and CB2 receptors.
It has an EC50 of 159 nM for human CB1 receptors.
Metabolism A-CHMINACA is not hydrolized by human carboxylesterases which increases its half-life.
Distribution A-CHMINACA has been sold as a designer drug with one sample having been seized by Polish authorities in Lublin.
It was also detected in samples taken in Toronto in 2020.
See also
5F-AB-PINACA 5F-ADB 5F-AMB AB-FUBINACA AB-CHFUPYCA AB-PINACA ADB-CHMINACA ADB-FUBINACA ADB-PINACA ADBICA APICA APINACA MDMB-CHMICA MDMB-CHMINACA MDMB-FUBINACA PX-3
References